Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE).
Saved in:
| Title: | Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE). |
|---|---|
| Authors: | Smoot K; Providence Brain and Spine Institute, Portland, OR, USA., Marginean H; Providence Brain and Spine Institute, Portland, OR, USA., Gervasi-Follmar T; Providence Brain and Spine Institute, Portland, OR, USA., Chen C; Providence Brain and Spine Institute, Portland, OR, USA., Repovic P; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA., Cohan S; Providence Brain and Spine Institute, Portland, OR, USA. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2023 Jul; Vol. 29 (8), pp. 956-966. Date of Electronic Publication: 2023 Jun 15. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Observational Study |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0970 |
|---|---|
| DOI: | 10.1177/13524585231175284 |
